Newron Pharmaceuticals S.p.A. | WebDisclosure

Basculer en Français

8295	Companies
114810	Keywords
55260	Articles
62423	Press releases

Headlines Articles Press releases Newron Pharmaceuticals S.p.A.

Home
Companies
Newron Pharmaceuticals S.p.A.

BRIEF

published on 09/19/2024 at 07:05, 2 months 2 days ago

Newron Pharmaceuticals présente ses résultats du premier semestre 2024 et son point sur ses activités

Essais Cliniques Evenamide Traitement De La Schizophrénie Premier Semestre 2024 Newron Pharmaceutique
BRIEF

published on 09/19/2024 at 07:05, 2 months 2 days ago

Newron Pharmaceuticals Presents H1 2024 Results and Business Update

Clinical Trials Newron Pharmaceuticals Evenamide Schizophrenia Treatment H1 2024
PRESS RELEASE

published on 09/19/2024 at 07:00, 2 months 2 days ago

Newron presents H1 2024 results and provides business update
Newron Pharmaceuticals presents H1 2024 financial results and operational highlights, focusing on evenamide studies for schizophrenia treatment and corporate developments

Financial Results Newron Pharmaceuticals Evenamide Schizophrenia Treatment H1 2024
BRIEF

published on 06/25/2024 at 17:50, 4 months 25 days ago

Newron Pharmaceuticals souligne la journée des investisseurs 2024 à New York

Essais Cliniques Schizophrénie Produits Pharmaceutiques Newron Evenamide Journée Des Investisseurs
BRIEF

published on 06/25/2024 at 17:50, 4 months 25 days ago

Newron Pharmaceuticals Highlights 2024 Investor Day in NYC

Investor Day Clinical Trials Schizophrenia Newron Pharmaceuticals Evenamide
PRESS RELEASE

published on 06/25/2024 at 17:45, 4 months 25 days ago

Newron Pharmaceuticals reports on its 2024 Investor Day in New York City
Newron Pharmaceuticals reports on its 2024 Investor Day in New York City, highlighting evenamide's potential in treating treatment-resistant schizophrenia. Leading experts present clinical data and benefits of evenamide

Clinical Data Schizophrenia 2024 Investor Day Newron Pharmaceuticals Evenamide
BRIEF

published on 06/18/2024 at 17:50, 5 months 2 days ago

Journée des investisseurs 2024 de Newron Pharmaceuticals, le 25 juin 2024, à New York

Schizophrénie Produits Pharmaceutiques Newron Evenamide Recherche Clinique Journée Des Investisseurs
BRIEF

published on 06/18/2024 at 17:50, 5 months 2 days ago

Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City

Investor Day Clinical Research Schizophrenia Newron Pharmaceuticals Evenamide
PRESS RELEASE

published on 06/18/2024 at 17:45, 5 months 2 days ago

Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City
Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City. Key opinion leaders to review findings on evenamide program for treatment-resistant schizophrenia

Investor Day Neuroscience Schizophrenia Newron Pharmaceuticals Evenamide
BRIEF

published on 06/05/2024 at 17:50, 5 months 15 days ago

Newron Pharmaceuticals to Host 2024 Investor Day in New York City

Investor Day New York City Schizophrenia Newron Pharmaceuticals Evenamide

1 2 ... 5

Accesswire

Published on 11/21/2024 at 09:00, 51 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 16 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 26 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 51 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 51 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:41, 10 minutes ago

Original-Research: 2G Energy AG (von First Berlin Equity Research GmbH): Buy
Published on 11/21/2024 at 09:01, 50 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 51 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 51 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 36 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.

Les Echos

Published on 11/21/2024 at 06:58, 2 hours 53 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 53 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 53 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 43 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 31 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE